The cutaneous analgesic effect of Class I antiarrhythmic drugs

Anesthesia and Analgesia

Volumn 104, Issue 4, 2007, Pages 955-958

  Tzeng, Jann Inn ^a,b   Cheng, Kuang I ^c   Huang, Kuo Lun ^a   Chen, Yu Wen ^a   Chu, Koung Shing ^c   Chu, Chin Chen ^a   Wang, Jhi Joung ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; FLECAINIDE; LIDOCAINE; MEXILETINE; QUINIDINE GLUCONATE; SODIUM CHLORIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANESTHETICS, LOCAL; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BUPIVACAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLECAINIDE; INJECTIONS, SUBCUTANEOUS; LIDOCAINE; MALE; MEXILETINE; PAIN MEASUREMENT; PAIN THRESHOLD; QUINIDINE; RATS; RATS, SPRAGUE-DAWLEY; REFLEX; SKIN; SODIUM CHANNEL BLOCKERS; TIME FACTORS;

EID: 34047266004     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000256882.13617.ad     Document Type: Article

References (17)

1. Fozzard HA, Lee PJ, Lipkind GM. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr Pharm Des 2005;11:2671-86.
2. Tremont-Lukats IW, Challapalli V, McNicol ED, et al. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005;101:1738-49.
3. Kowey PR. Pharmacological effects of antiarrhythmic drugs. Arch Intern Med 1998;158:325-32.
4. Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Pharmacol 2001;52:21s-34s.
5. Kowey PR, Marinchak RA, Rials SJ, Bharucha DB. Classification and pharmacology of antiarrhythmic drugs. Am Heart J 2000;140:12-20.
6. McLure HA, Rubin AP. Review of local anaesthetic agents. Minerva Anesthesiol 2005;71:59-74.
7. Scholz A. Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. Br J Anaesth 2002;89:52-61.
8. Wood JN, Baker M. Voltage-gated sodium channels. Curr Opin Pharmacol 2001;1:17-21.
9. Khan MA, Gerner P, Sudoh Y, Wang GK. Use of a charged lidocaine derivative, tonicaine, for prolonged infiltration anesthesia. Reg Anesth Pain Med 2002;27:173-9.
10. Khan MA, Gerner P, Wang GK. Amitriptyline for prolonged cutaneous analgesia in the rat. Anesthesiology 2002;96:109-16.
11. 50. Biometrics 1999;55:1030-7.
12. Lipkind GM, Fozzard HA. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 2005;68:1611-22.
13. Catterall WA, Goldin AL, Waxman SG. International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005;57:397-409.
14. Funao T, Oda Y, Tanaka K, Asada A. The P-glycoprotein inhibitor quinidine decreases the threshold for bupivacaine-induced, but not lidocaine-induced, convulsions in rats. Can J Anaesth 2003;50:805-11.
15. Hewitt KE, Stys PK, Lesiuk HJ. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury. Brain Res 2001;898:281-7.
16. + channel blockers in two rat models of neuropathic pain. Eur J Pharmacol 2003;458:275-82.
17. Ichimata M, Kitano T, Ikebe H, et al. Flecainide reverses neuropathic pain and suppresses ectopic nerve discharge in rats. Neuroreport 2001;12:1869-73.